What's Happening?
The Department of Justice (DOJ) has announced its first declination of a healthcare company, Campus Eye Management Holdings, under the new 2026 Corporate Enforcement and Voluntary Self-Disclosure Policy. While the company was not prosecuted, its founder
and former CEO, E. Bruce DiDonato, was indicted on charges of healthcare fraud and violating the Anti-Kickback Statute. The DOJ credited Campus Eye for its prompt self-disclosure, full cooperation, and significant remediation efforts, which included revising policies and enhancing compliance controls.
Why It's Important?
This declination marks a significant development in the DOJ's approach to corporate enforcement, highlighting the importance of voluntary self-disclosure and cooperation in avoiding prosecution. It underscores the DOJ's focus on holding individual executives accountable while encouraging companies to invest in robust compliance programs. The decision serves as a precedent for other companies, illustrating the potential benefits of proactive compliance and cooperation with regulatory authorities.
What's Next?
Companies in the healthcare sector and beyond may reevaluate their compliance strategies in light of the DOJ's new enforcement policy. The emphasis on executive accountability suggests that businesses should be prepared to provide detailed information about individual misconduct. As the DOJ continues to implement its policy, more companies may seek to align their practices with the expectations outlined in the Corporate Enforcement and Voluntary Self-Disclosure Policy to mitigate legal risks.
